Pharmaceutics workshops

New approach methodologies can support drug safety and efficacy evaluation while improving the mechanistic understanding of human disease and therapeutic response. This workshop addresses two barriers to their wider use: awareness of available applications and confidence that their results are biologically relevant, reproducible and translatable. Pharmaceutical developers, regulators and biomedical researchers will discuss validation, standardisation and integration of NAM-based evidence into research and development. Sessions consider human-based models, organoids, tissue microenvironments, organ-on-chip systems and computational approaches, alongside regulatory and industry implementation challenges. In-person attendees can explore National Medical Phantom Library demonstrations during breaks. The workshop takes place on 20–21 October 2026, starting at 10:00 EDT (America/New_York) on each day. Both in-person participation and a live webcast are available; in-person attendance is encouraged for fuller discussion. In-person registration closes at 17:00 EDT on 13 October. Webinar registration remains available through the end of the workshop and supplies individual connection details. Participants are responsible for their own meals and refreshments.